John Larsen, Morten Andersen, Lars Bjerrum, Jakob Kragstrup, Lars F Gram
{"title":"心肌梗死史患者降脂药物使用不足及血清胆固醇测定。","authors":"John Larsen, Morten Andersen, Lars Bjerrum, Jakob Kragstrup, Lars F Gram","doi":"10.1097/01.hjr.0000048740.87586.f8","DOIUrl":null,"url":null,"abstract":"Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well documented, particularly in patients with established ischaemic heart disease. However, intensity of the use o...","PeriodicalId":79345,"journal":{"name":"Journal of cardiovascular risk","volume":"10 1","pages":"61-4"},"PeriodicalIF":0.0000,"publicationDate":"2003-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction.\",\"authors\":\"John Larsen, Morten Andersen, Lars Bjerrum, Jakob Kragstrup, Lars F Gram\",\"doi\":\"10.1097/01.hjr.0000048740.87586.f8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well documented, particularly in patients with established ischaemic heart disease. However, intensity of the use o...\",\"PeriodicalId\":79345,\"journal\":{\"name\":\"Journal of cardiovascular risk\",\"volume\":\"10 1\",\"pages\":\"61-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cardiovascular risk\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.hjr.0000048740.87586.f8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiovascular risk","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.hjr.0000048740.87586.f8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction.
Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well documented, particularly in patients with established ischaemic heart disease. However, intensity of the use o...